Home Applications 201046 Application 201046
Type ANDA
Sponsor LUPIN LTD Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 RANOLAZINE RANOLAZINE TABLET, EXTENDED RELEASE;ORAL 500MG No No 002 RANOLAZINE RANOLAZINE TABLET, EXTENDED RELEASE;ORAL 1GM No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A201046-001 RANOLAZINE RANOLAZINE 500MG TABLET, EXTENDED RELEASE / ORAL AB 2013-07-29 A201046-002 RANOLAZINE RANOLAZINE 1GM TABLET, EXTENDED RELEASE / ORAL AB 2013-07-29
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 3 of 3 · 90 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A201046-001 RANOLAZINE 500MG TABLET, EXTENDED RELEASE / ORAL AB 2013-07-29 3a93d1ddd44b…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A201046-002 RANOLAZINE 1GM TABLET, EXTENDED RELEASE / ORAL AB 2013-07-29 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A201046-001 RANOLAZINE 500MG TABLET, EXTENDED RELEASE / ORAL AB 2013-07-29 f41ea6bd6efb…2022-10-28 04:53 UTC 2022-10 A201046-002 RANOLAZINE 1GM TABLET, EXTENDED RELEASE / ORAL AB 2013-07-29 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 A201046-001 RANOLAZINE 500MG TABLET, EXTENDED RELEASE / ORAL AB 2013-07-29 e64feba35796…2022-09-29 23:25 UTC 2022-09 A201046-002 RANOLAZINE 1GM TABLET, EXTENDED RELEASE / ORAL AB 2013-07-29 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A201046-001 RANOLAZINE 500MG TABLET, EXTENDED RELEASE / ORAL AB 2013-07-29 cb3db0bc1861…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A201046-002 RANOLAZINE 1GM TABLET, EXTENDED RELEASE / ORAL AB 2013-07-29 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A201046-001 RANOLAZINE 500MG TABLET, EXTENDED RELEASE / ORAL AB 2013-07-29 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A201046-002 RANOLAZINE 1GM TABLET, EXTENDED RELEASE / ORAL AB 2013-07-29 a50c72e98297…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 3 · 90 observed states.
Observed Orange Book exclusivity history# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 9 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 60687-460 Ranolazine Ranolazine American Health Packaging ANDA Current 68180-354 RANOLAZINE RANOLAZINE Lupin Pharmaceuticals, Inc. ANDA Current 68180-354 RANOLAZINE RANOLAZINE Lupin Pharmaceuticals, Inc. ANDA Current 68180-354 RANOLAZINE RANOLAZINE Lupin Pharmaceuticals, Inc. ANDA Current 68180-354 RANOLAZINE RANOLAZINE Lupin Pharmaceuticals, Inc. ANDA Current 68180-355 RANOLAZINE RANOLAZINE Lupin Pharmaceuticals, Inc. ANDA Current 68180-355 RANOLAZINE RANOLAZINE Lupin Pharmaceuticals, Inc. ANDA Current 68180-355 RANOLAZINE RANOLAZINE Lupin Pharmaceuticals, Inc. ANDA Current 68180-355 RANOLAZINE RANOLAZINE Lupin Pharmaceuticals, Inc. ANDA Current
Documents# Document, Submission type, Date table Document Submission type Date 32080 ORIG 2013-07-31